RTTNews | Aug 29, 2021 11:34PM EDT

23:34 Sunday, August 29, 2021 (RTTNews.com) - Contract drug manufacturer Catalent Inc. (CTLT) has agreed to acquire closely held vitamin and supplements maker Bettera Holdings for $1 billion in cash, the Wall Street Journal reported citing people familiar with the matter.

The deal would expand Catalent's manufacturing capabilities for vitamins, minerals and supplements to make them in gummy form. The deal expected to be announced Monday morning, the Journal reported.

The deal is expected to close by the end of the fourth quarter.

Read the original article on RTTNews ( https://www.rttnews.com/3221673/catalent-to-acquire-bettera-for-1-bln-report.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved